Back to search

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.

Data up to Jan 2025

Published2002
Citations108
References21

Total Citations Per Year

Abstract

References (21)

Cloning of a novel receptor expressed in rat prostate and ovary.

1996 • 4,782 citations

Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β

1998 • 4,127 citations

Cancer statistics, 2000

2000 • 3,907 citations

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

1999 • 3,362 citations

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1999 • 1,858 citations

Generation and reproductive phenotypes of mice lacking estrogen receptor β

1998 • 1,680 citations

Molecular Determinants for the Tissue Specificity of SERMs

2002 • 1,114 citations

Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening

1993 • 1,014 citations

PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY

1997 • 609 citations

Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry

1997 • 364 citations

Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

2000 • 358 citations

Estrogen Receptor Expression in Prostate Cancer and Premalignant Prostatic Lesions

1999 • 237 citations

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer

1998 • 181 citations

Dissecting the pathways to death

2000 • 155 citations

Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions

2002 • 152 citations

Estrogen receptor-?: Implications for the prostate gland

1999 • 137 citations

An estrogen receptor basis for raloxifene action in boneProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998.

1999 • 83 citations

Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy

2000 • 56 citations

The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor

1995 • 36 citations

Selective estrogen receptor modulators: pharmacological profile in the rat uterus.

1996 • 32 citations

The Treatment of Hormone Refractory Prostate Cancer

2003 • 19 citations

Cited By (0)

Loading...
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in… (2002) – PubMed | Metascience Observatory Explorer